Database on monoclonal antibodies to Cytokeratins

Oral Oncology

Volumn 40, Issue 3, 2004, Pages 236-256

  Upasani, Ojaswini S ^a   Vaidya, Milind M ^a   Bhisey, Avinash N ^a  

^a CANCER RESEARCH INSTITUTE   (India)

Author keywords

Cytokeratins; Database; Immunoblotting; Immunohistochemisty; Monoclonal antibodies

Indexed keywords

BIOLOGICAL MARKER; CYTOKERATIN; EPITOPE; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

CROSS REACTION; DATA BASE; EPITHELIUM; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT; LABORATORY DIAGNOSIS; LEUKOPLAKIA; MOUTH CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; TISSUE FIXATION; TISSUE SECTION; TISSUE SPECIFICITY;

EID: 1642431598     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2003.08.022     Document Type: Review

References (101)

1. Moll R., Franke W.W., Schillen D., Geiger B., Kepler H. The catalog of human cytokeratin. patterns of expression in normal epithelia, tumors and cultured cells Cell. 31:1982;11-24.
2. Moll R., Schiller D.L., Franke W.W. Identification of protein IT of the intestinal cytoskeleton as novel type I cytokeratin with unusual properties and expression patterns. J. Cell Biol. 111:1990;567-580.
3. Coulombe P.A., Omary M.B. 'Hard' and 'soft' principles defining the structure, function and regulation of keratin intermediate filaments. Curr. Opin. Cell Biol. 14:2002;110-122.
4. Morgan P.R., Shirlow P.J., Johnson N.W., Leigh I.M., Lane E.B. Potential applications of anti-keratin antibodies in oral diagnosis. J. Oral Pathol. 171:1987;212-222.
5. Eichner R., Sun T.T., Achi U. The role of keratin subfamilies and keratin pairs in the formation of human epidermal intermediate filaments. J. Cell Biol. 102:1986;1767-1777.
6. Sun T.T., Eichner R., Schermer A., Cooper D., Nelson W.G., Weiss R.A. Classification, expression and possible mechanisms of evolution of mammalian epithelial keratins. A unifying model Aeisne A.J., Van der Woued G.F., Topp W.C., Watson J.E. Transformed Phenotype: Cancer Cells. Vol. 1. 1984;169-176 Cold Spring Harbour Laboratory, New York.
7. Clausen H., Moe D., Buschard K., Dabelsteen E. Keratin patterns in human oral mucosa. J. Oral Pathol. 15:1986;36-42.
8. Franke W.W., Schmid E., Schiller D.I.et al. Differentiation-related patterns of expression of proteins of intermediate filaments in tissues and cultured cells. Cold Spring Harbor Symp. Quant. Biol. 46:1982;43-53.
9. Chisholm J.C., Houliston E. Cytokeratin filament assembly in the preimplantation mouse embryo. Development. 101:1987;565-582.
10. Kasper M., Karsten U., Stosiek P., Moll R. Distribution of intermediate filament proteins in the human enamel organ. unusually complex pattern of expression of cytokeratin polypeptides and the vimentin Differentiation. 40:1989;207-214.
11. Lehtonen E., Lehto V.P., Vatio T., Bradley R.A., Virtanen I. Expression of cytokeratin polypeptides in mouse oocytes and preimplantation embryos. Dev. Biol. 100:1983;158-165.
12. Leube R.E., Bosch F.X., Romano V., Zimbelmann R., Hofler H., Franke W.W. Cytokeratin expression in simple epithelia. III. Detection of mRNA encoding human cytokeratins nos. 8 and 18 in normal and tumor cells by hybridiztion with cDNA sequences in vitro and in situ Differentiation. 33:1986;69-85.
13. Shabana A.H.M., Ouhayoun J.P., Sawaf M.H., Forest N. A comparative biochemical and immunological analysis of cytokeratin patterns in the oral epithelium of the miniature pig and man. Archs Oral Biol. 34(4):1989;249-259.
14. Ogden G.R., McQueen S., Chisholm D.M., Lane E.B. Keratin profiles of normal and malignant oral mucosa using exfoliative cytology. J. Clin. Pathol. 46:1993;352-356.
15. Steinert P.M., Roop D.R. Molecular and cellular biology of intermediate filaments. Annual Rev. Biochem. 57:1988;593-625.
16. Bosch F.X., Ouhayoun J.P., Bader B.L., Collin C., Grund C., Lee I., Franke W.W. Extensive changes in cytokeratin expression patterns in pathologically affected human gingival. Virchows Archiv. B Cell Pathol. 58:1989;59-77.
17. Ogden G.R., Chisholm D.M., Leigh I.M., Lane E.B. Cytokeratin profiles in dyskeratosis congenital. an immunocytochemical investigation of lingual hyperkeratosis J. Oral Pathol. Med. 21:1992;353. -357.
18. Lane E.B., Alexander C.M. Use of keratin antibodies in tumor diagnosis. Seminars in Cancer Biol. 1:1990;165-179.
19. Osborn M., Altmansberger M., Debus E., Weber K. Intermediate filaments as markers for determining the histogenetic origin of human tumors. J. Submicrosc. Cytol. 16:1984;149.
20. Moll R., Kepler R., Franke W.W. Complex polypeptide cytokeratin patterns observed in certain human carcinomas. Differentiation. 23:1983;256-265.
21. Moll R. Diversity of cytokeratins in carcinomas. Acta Histochem. 34:1987;37-44.
22. Osborn M. Intermediate filament typing of cells and tumors yeilds information useful in histology and cytology. Fortschritte der Zoologie. 34:1987;261-273.
23. Pindborg J.J., Reichart P.A., Smith C.J., van der Wall I. Histological typing of cancer and precancer of the oral mucosa. 2nd ed. 1997;Spinger-Verlag, Berlin. pp. 224-227.
24. Jussawalla DI, Yeole BB, Natekar MV. Cancer incidence in greater Bombay, 1973-78; An epidemiological study (Bombay, Indian Cancer Society) 1985.
25. Gupta P.C., Bhonsle R.B., Murti P.R., Daftary D.K., Mehta F.S., Pindborg J.J. An epidemiological assessment of cancer risk of oral precancerous lesions in India with special reference to nodular leukoplakia. Cancer. 63:1989;2247-2251.
26. Vigneswaran N., Peters K.P., Hornstein O.P., Haneke E. Comparison of cytokeratin, filaggrin and involucrin profiles in oral leukoplakias and squamous carcinomas. J. Oral Pathol. Med. 18:1989;377-390.
27. Vaidya M.M., Borges A.M., Pradhan S.A., Rajpal R.M., Bhisey A.N. Altered keratin expression in buccal mucosal squamous cell carcinoma. J. Oral Pathol. Med. 18:1989;282-286.
28. Kannan S., Balaram P., Chandran G.J., Pillai M.R., Mathew B., Nalinkumari K.R., Nair M.K. Alterations in expression of terminal differentiation markers of keratinocytes during oral carcinogenesis. Pathobiology. 62:1994;127-133.
29. Heyden A., Huitfeldt H.S., Koppang H.S., Thrane P.S., Bryne M., Brandtzaeg P. Cytokeratins as epithelial differentiation markers in premalignant and malignant oral lesions. J. Oral Pathol. Med. 21:1992;7-11.
30. Marley J.J., Robinson P.A., Hume W.J. Expression of human cytokeratin 14 in normal, premalignant and malignant oral tissue following isolation by plaque differential hybridization. Oral Oncol. Eur. J. Cancer. 30B(5):1994;305-311.
31. Su L., Morgan P.R., Lane E.B. Protein and mRNA expression of simple epithelial keratins in normal, dysplastic and malignant oral epithelia. Am. J. Pathol. 145:1994;1349-1357.
32. Vaidya M.M., Borges A.M., Pradhan S.A., Bhisey A.N. Cytokeratin expression in squamous cell carcinomas of the tongue and alveolar mucosa. Eur. J. Cancer Oral Oncol. 32:1996;333-336.
33. Lindberg K., Rheinwald J.G. Suprabasal 40 kD keratin (K19) expression as an immunohistoloigc marker of premalignancy in oral epithelium. Am. J. Pathol. 134(1):1989;89-98.
34. Vaidya M.M., Sawant S.S., Borges A.M., Ogale S.B., Bhisey A.N. Cytokeratin expression in precancerous lesions of the human oral cavity. Eur. J. Cancer Oral Oncol. 34:1998;264-267.
35. Luna E.J., Hitt A.L. Cytoskeleton plasma membrane interactions. Science. 1992;258-263.
36. Stappenbeck T.S., Lamb J.A., Corcoran C.M., Green K.J. Phosphorylation of the desmoplakin COOH terminus negatively regulates its interaction with keratin intermediate filament networks. J. Biol. Chem. 269:1994;29351-29354.
37. Borradori L., Sonnenberg A. Hemidesmosoms roles in adhesion, signaling and human diseases. Curopin. Cell Biol. (United States). 8(5):1996;647-656.
38. Purkins P.E., Steel J.B., Mackenzie I.C., Nathrath W.B.J., Leigh I.M., Lane E.B. Antibody markers of basal cells in complex epithelia. J. Cell Sci. 9:1990;739-750. (1-5).
39. Huszar M., Gigi Leitaner O., Moll R., Franke W.W., Geiger B. Monoclonal antibodies to various acidic (type I) cytokeratinof startified epithelia. Differentiation. 31:1986;141-153. (6-7).
40. Draeger A., Nathrath W.B.J., Lane E.B., Sundstrom B.E., Stigbrand T.I. Cytokeratins, smooth muscle actin and vimentin in human normal salivary gland and pleomorphic adenomas. APMIS. 99:1991;405-415. (7).
41. Gigi-Leitner O., Geiger B., Levy R., Czernobilsky B. Cytokeratin expression in squamous metaplasia of the human uterine cervix. Differentiation. 31:1986;191-205. (7,125-126).
42. Mare S., Van Erp P.E.J., Van De Kerkhof P.C.M. Epidermal hyperproliferation assessed by the monoclonal antibody Ks8.12 on frozen sections. J. Invest. Dermatol. 92:1989;130-131. (7).
43. Woodcock-Mitchell J., Eichner R., Nelson W.G., Sun T.T. Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J. Cell Biol. 95:1982;580-588. (8-10).
44. Franklin R.M., Emmons L.R., Emmons R.P., Oommen A., Pink J., Rijnbeck A.M., Schentzler M., Tuderman L., Vainio E. Monoclonal antibody which recognizes a common antigenic determinant on intermediate filament proteins,actin & myosin. Hybridoma. 2:1983;275-285.
45. Van Muijen G.N.P., Ruiter D.J., Franke W.W., Achtstatter T., Haasnoot W.H.B., Ponec M., Warhaar S.O. Celltype heterogenicity of cytokeratin expression in complex specific for cytokeratins no. 4 and 13. Exp. Cell Res. 162:1986;97-113. (12-14).
46. Collin C., Moll R., Kubicka S., Ouhayoun J.P., Franke W.W. Characterization of human cytokeratin 2, an epidermal cyto-skeletal protein synthesized late during differentiation. Exp. Cell Res. 202:1992;132-141. (15).
47. Erb K., Borup-Chistensen P., Ditzel H., Chermitz J., Hass H., Jensenius J.C. Characterization of a human-human hybridoma antibody, c-ou1, directed against a colon tumor-associated antigen. Hybridoma. 11:1992;121-134. (16).
48. Escurat M., Phamgia H., Huc C., Pouplard-Barthelaix A., Boitard C., Bach J.F., Gros F., Portier M.M. A new monoclonal antibody recognizing the amino-terminal consensus sequence of vertebrate intermediate filament proteins. FEBS Lett. 253:1989;157-162. (17).
49. Lane E.B., Bartek J., Purkis P.E., Leigh I.M. Keratin antigens in differentiating skin. Ann. N Y Acad. Sci. 455:1985;241-258. (18,106-112).
50. Stasiak P.C., Purkis P.E., Leigh I.M., Lane E.B. Keratin 19. predicted amino acid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins J. Invest. Dermatol. 92:1989;707-716. (18).
51. Karsten U., Papsdorf G., Roloff G., Stolley P., Abel H., Walther I., Weiss H. Monoclonal anti-cytokeratin antibody from a hybridoma clone generated by electrofusion. Eur. J. Cancer Clin. Oncol. 21:1985;733-740. (19).
52. Nagle R.B., Bocker W., Davis J.R., Heid H.W., Kaufmann M., Lucas D.O., Jarasch E.D. Characterization of breast carcinomas by two monoclonal antibodies distinguishing myoepithelial from luminal epithelia. J. Histochem. Cytochem. 34:1986;869-881. (20,68).
53. Nagle R.B., Lucas D.O., Mcdaniel K.M., Clark V.A., Schmalzel G.M. New evidence linking mammary and extramammary paget cells to a common cell phenotype. Am. J. Clin. Pathol. 83:1985;431-438. (20,68-69).
54. Wetzels R.H.W., Kuijpers H.J.H., Lane E.B., Leigh I.M., Troyanovsky S.M., Holland R., Van Haelst U.J.G.M., Ramaekers F.C.S. Basal cell-specific and hyperproliferation-related keratins in human breast cancer. Am. J. Pathol. 138:1991;751-763. (20,22,70).
55. Viac J., Reano A., Brochier J., Staquet M.J., Thivolet J. Reactivity pattern of a monoclonal antikeratin antibody(KL1). J. Invest. Dermatol. 81:1983;351-354. (21).
56. Eto H., Hashimoto K., Kobayashi H., Matsumoto M., Kanzaki T., Mehregan A.H., Weiss R.A. Monoclonal antikeratin antibody. production, characterization and immuno histochemical application J. Invest. Dermatol. 84:1985;404-409. (22).
57. Brabon A.C., Williams J.F., Cardiff R.D. A monoclonal antibody to a human breast tumor protein released in response to estrogen. Cancer Res. 44:1984;2704-2710. (23).
58. Chan R., Edwards B.F., Hu R., Rossitto P.V., Min B.H., Lund J.K., Cardiff R.D. Characterization of two monoclonal antibodies in an immuno-histochemical study of keratin 8 & 18 expression. Am. J. Clin. Pathol. 89:1988;472-480. (23,24).
59. Bailly J., Darmon M., Juhlin L., De'marchez M. A new marker of epidermal differentiation associated with membrane coating granules. Acta Dermatol. Venereol(Stockh). 72:1992;337-344. (25).
60. Dhouailly D., Xu C., Manabe M., Schermer A., Sun T.T. Expression of hair-related keratin in a soft epithelium. sub-populations types of differentiation Exp. Cell Res. 181:1989;141-158. (26).
61. Kemler R., Brulet P., Schnebelen M.T., Gaillard J., Jacob F. Reactivity of monoclonal antibodies against intermediate filament proteins during embryonic development. J. Embryol. Exp. Morphol. 64:1981;45-60. (27,28).
62. Lauerova L., Kovarik J., Bartek J., Rejthar A., Vojtesek B. Novel monoclonal antibodies defining epitope of human cyto-keratin 18 molecule. Hybridoma. 7:1988;495-504. (29,30).
63. Lane E.B. Monoclonal antibodies provide specific intramolecular markers for the study of epithelial tonofilament organization. J. Cell Biol. 92:1982;665-673. (31-36).
64. Schaafsma H.E., Ramaekers F.C.S., Van Muijen G.N.P., Lane E.B., Leigh J.M., Robben H., Huijsmans A., Ooms E.C.M., Ruiter D.J. Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis tumor progression. Am. J. Pathol. 136:1990;329-343. (37,95).
65. Sundstrom B.E., Nathrath W.B.J., Stigbrand T.I. Diversity in immunoreactivity of tumor-derived cytokeratin monoclonal antibodies. J. Histochem. Cytochem. 37:1989;1845-1854. (38-42).
66. Holthofer H., Miettinen A., Lehto V.P., Lehtonen E., Virtanen I. Expression of vimentin and cytokeratins types of intermediate filament proteins in developing and adult human kidneys. Lab. Invest. 50:1984;552-559. (43,44).
67. Holthofer H., Miettinen A., Paasivuo R., Lehto V.P., Linder E., Alfthan O., Virtanen I. Cellular origin and differentiation of renal carcinomas. a fluorescence microscopic study antibodies and lectins Lab. Invest. 49:1983;317-326. (43,46).
68. Mori M., Tatemoto Y., Yamamoto N., Okada Y. Immunohistochemical localization of intermediate filament proteins in calcifying epithelial odontogenic tumors. J. Oral Pathol. 17:1988;236-240. (43).
69. Virtanen I., Miettinen M., Lehto V.P., Kariniemi A.L., Paasivuo R. Diagnostic application of monoclonal antibodies to intermediate filaments. Ann. NY Acad. Sci. 455:1985;635-648. (43-45).
70. Ramaekers F., Huysmans A., Moesker O., Kant A., Jap P., Herman C., Vooijs P. Monoclonal antibody to keratin filaments, specific for glandular epithelia and their tumors. use in surgical pathology Lab. Invest. 49:1983;353-361. (47).
71. Ramaekers F., Huysmans A., Schaart G., Moesker O., Vooijs P. Tissue distribution of keratin 7 as monitored by a monoclonal antibody. Exp. Cell Res. 170:1987;235-249. (47,101-105).
72. Ramaekers F., Van Niekerk C., Poels L., Schaafsma E., Huijsman A., Robben H., Schaart G., Vooijs P. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am. J. Pathol. 136:1990;641-655. (47,96,97,101,103-105).
73. Angus B., Purvis J., Stock D., Westley B.R., Samson A.C.R., Routledge E.G., Carpenter F.H., Horne C.H.W. NCL-5D3. A new monoclonal antibody recognizing low molecular weight cytokeratins effective paraffin-embedded tissue J. Pathol. 153:1987;377-384. (48).
74. Ivanyi D., Ansink A., Groeneveld E., Hageman P.C., Mooi W.J., Heintz A.P.M. New monoclonal antibodies recognizing epidermal differentiation- associaed keratins in carcinoma of the vulva. J. Pathol. 159:1989;7-12. (49,50).
75. Vos J.H., Van Den Ingh Tsgam, De Neijs M., Van Mil F.N., Ivanyi D., Ramaekers F.C.S. Immunohistochemistry with keratin monoclonal antibodies in canine tissues. J. Vet. Med. 39:1992;721-740. (49,113,114).
76. Pulford K.A.F., Gatter K.C., Mason D.Y. The characterization of two monoclonal anti-keratin antibodies and their use in the study of epithelial disorders. Histopathology. 9:1985;825-840. (51,52).
77. Bartek J., Vojtesek B., Staskova Z., Bartkova J., Kerekes Z., Rejthar A., Kovarik J. A series of 14 new monoclonal antibodies to keratins. characterization and value in diagnostic histopathology J. Pathol. 164:1991;215-224. (53,55-59,85-92).
78. Kovarik J., Rejthar A., Lauerova L., Vojtesek B., Bartkova J. Monoclonal antibodies against individual cytokeratins in the detection of metastatic spread. Int. J. Cancer Suppl. 3:1988;50-55. (53-59).
79. Moll R., Achtstatter T., Becht E., Balcarova-Stander J., Ittensohn M., Franke W.W. Cytokeratins in normal and malignant transitional epithelium. maintenance of expression of carcinoma cell culture lines Am. J. Pathol. 132:1988;123-144. (60-62,100).
80. Gown A.M., Vogel A.M. Monoclonal antibodies to human intermediate filament proteins. distribution of filament proteins in normal human tissues Am. J. Pathol. 114:1984;309-321. (63,65,66).
81. Gown A.M., Vogel A.M. Monoclonal antibodies to intermediate filament proteins of human cells. unique and cross-reacting antibodies J. Cell Biol. 95:1982;414-424. (63-66).
82. Franke W.W., Winter S., Overbeck J., Gudat F., Heitz P.U., Stahli C. Identification of the conserved, conformation-dependent cytokeratin epitope recognized by monoclonal antibody (LU-5). Virchows Arch. A. 411:1987;137-147. (67).
83. Jarasch E.D., Nagle R.B., Kaufmann M., Maurer C., Bocker W.J. Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins. Hum. Pathol. 19:1988;276-289. (68,69).
84. Dairkee S.H., Blayney C., Smith H.S., Hackett A.J. Monoclonal antibody that defines human myoepithelium. PNAS. 82:1985;7409-7413. (71).
85. Dairkee S.H., Blayney-Moore M., Smith H.S., Hackett A.J. Concurrent expression of basal and luminal epithelial markers in cultures of normal human breast analyzed using MAbs. Differentiation. 32:1986;93-100. (71).
86. Makin C.A., Bobrow L.G., Bodmer W.F. Monoclonal antibody to cytokeratin for use in the routine histopathology. J. Clin. Pathol. 37:1984;975-983. (72).
87. Cintorino M., Del Vecchio M.T., Bugnoli M., Petracca R., Leoncini P. Cytokeratin pattern in normal and pathological bladder urothelium. immunohistochemical investigation using mabs J. Urol. 139:1988;428-432. (73-75).
88. Bartek J., Taylor Papadimitriou J., Miller N., Millis R. Patterns of expression of keratin 19 as detected with monoclonal antibodies in human breast tissues and tumours. Int. J. Cancer. 36:1985;299-306. (76,77).
89. Southgate J., Williams H.K., Trejdosiewicz L.K., Hodges G.M. Primary culture of human oral epithelial cells. growth requirements & expression of differentiated characteristics Lab. Invest. 56:1987;211-223. (78,79).
90. Dixon M.J., Robinson V., White A., Ferguson M.W.J. Monoclonal antibodies recognising stage and region specific epitopes in embryonic mouse palatal epithelial cells. J. Anat. 183:1993;423-438. (80-83).
91. Franke W.W., Winter S., Schmid E., Sollner P., Hammerling G., Achstatter T. Monoclonal cytokeratin antibody recognizing a heterotypic complex. immunological probing filaments and in solution Exp. Cell Res. 173:1987;17-37. (84).
92. Kovarik J., Bartek J., Rejthan A., Bartkova J., Lauerova L. Development, characterization & clinical applications of a new antikeratin monoclonal antibody. Eur. J. Cancer Clin. Oncol. 21:1985;1396. (93).
93. Pruss R.M., Mirsky R., Raff M.C., Thorpe R., Dowding A.J., Anderton B.H. All classes of intermediate filaments share a common antigenic determinant defined by a monoclonal antibody. Cell. 27:1981;419-428. (94).
94. Karsten U., Widmaier R., Kunde D. Monoclonal antibodies against antigens of the human mammary carcinoma cell line MCF-7. Arch Geschwulsforsch. 53:1983;529-536. (98).
95. Smedts F., Ramaekers F., Robben H., Pruszzczynski M., Van Muijen G., Lane B., Leigh I., Vooijs P. Changing patterns of keratin expression during progression of cervical intraepithelial neoplasia. Am. J. Pathol. 136:1990;657-668. (99,101,105).
96. Osborn M., Van Lessen G., Weber K., Kloppel G., Altmannsberger M. Methods in laboratory investigation. differential diagnosis of gastrointestinal carcinomas by keratin polypeptides Lab. Invest. 55:1986;497-504. (115,116).
97. Osborn M., Mazzoleni G., Santini D., Marrano D., Martinelli G., Weber K. Villin, intestinal brush border hydrolases and keratin polypeptides in intestinal metaplasia and gastric cancer; an immunohistologic study emphasizing the different degrees of intestinal and gastric differentiation in signet ring cell carcinomas. Virchows Arch. A Pathol. Anat. 413:1988;303-312. (116).
98. Debus E., Moll R., Franke W.W., Weber K., Osborn M. Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies. Am. J. Pathol. 114:1984;121-130. (117-121).
99. Jahn L., Fouquet B., Rohe K., Franke W.W. Cytokeratins in certain endothelial & smooth muscle cells oftwo taxonomically distant vertebrate species, X. laevis & man. Differentiation. 36:1987;234-254. (122-124).
100. Gigi-Leitner O., Geiger B. Antigenic interrelationship between the 40kd cytokeratin polypeptide and desmoplankins. Cell Motil. Cytoskel. 6:1986;628-639. (125,126).
101. Heikinheimo K., Persson S., Kindblom L.G., Morgans P.R., Virtanen I. Expression of different cytokeratin subclasses in human chordoma. J. Pathol. 164:1991;145-150. (126).